Skip to main content
. 2015 Dec 15;7(3):3332–3340. doi: 10.18632/oncotarget.6620

Figure 4. Impact of FAM83D expression level on overall survival in patients with: A. Breast cancer, B. Cervical squamous cell carcinoma, C. Kidney renal clear cell carcinoma, D. Brain lower grade glioma, E. Liver hepatocellular carcinoma, F. Lung adenocarcinoma, G. Kidney renal papillary cell carcinoma, H. Uterine corpus endometrioid carcinoma, and I. Skin cutaneous melanoma.

Figure 4

“NP” refers to “Number of Patients”, whereas “NE” refers to “Number of Events”. Kaplan-Meier estimates of overall survival according to the FAM83D expression are presented. The p values were obtained from a log-rank test among two groups.